A participatory discussion with key exosome stakeholders and the regulatory requirements for exosome therapies.
CCRM Australia is organising a series of workshops that seek to encourage dialogue between different stakeholders in research, commercial, clinical and the regulatory ecosystem on regulatory issues impacting the translation and introduction of advanced therapies into the market.
In our first workshop, we will be focusing on exosomes/extracellular vesicles. The workshop will be conducted by Dr Sowmya Viswanathan, former co-Chair, Cellular Manufacturing and Clinical Trials at the Canadian Cell Therapy Stakeholder Group. The workshop will also involve guests Prof Andrew Hill, Associate Provost (Research and Industry Engagement) at La Trobe University and Former ISEV President together with Prof Luis Ortiz MD, Clinical and Translational Science Institute, University of Pittsburgh and current ISCT Exosome Committee Member.
Key discussion topics include manufacturing, regulatory, quality control, and clinical concerns of exosome/extracellular vesicles therapies.
CCRM Australia welcomes attendees to the workshop and invites suggestions for discussion items in addition to those listed above.
The Exosome Regulatory Workshop will adopt an online format via Zoom and held on 23rd July 2021 at 9 am (AEDT).
To register your interest in participating and contributing to the discussion, please contact: CCRM Australia: Dr Chih Wei Teng at email@example.com
2021 CCRM Australia Regulatory Workshop: Exosome Spotlight Flyer